|Cardiology Now is a series of short podcast discussions between Dr Payal Kohli of the University of California San Francisco and experts in cardiovascular medicine. Dr Kohli and guests provide concise perspective for primary care practice on what’s new in the prevention, assessment, and management of cardiovascular disease. More here… |
What Are Pleiotropic Effects? The Role of Statins in Decreasing Inflammation
March 11, 2013
It would be a mistake to attribute all beneficial outcomes obtained from statins solely to cholesterol lowering. Statins have pleiotropic effects—that is, they are simultaneously capable of producing more than one benefit, and in cardiovascular risk reduction, they accomplish more than simply lowering cholesterol.
Residual Cardiovascular Risks: Don’t Forget Kidney and Vascular Disease
February 28, 2013
Typical interventions in persons without chronic kidney disease—-for example, smoking cessation, treatment of blood pressure elevations to target, and diabetic control are essential. SHARP and TNT have added to our knowledge. Aggressive cholesterol lowering (probably also affecting LDL particle number as well as traditional measures of LDL) seems to afford better outcomes by lessening residual risk in those with CKD.
Showing 11 - 20 of 47 results.
Scimitar Syndrome in Turner Syndrome
May 16, 2011
A 39 year-old female with Turner Syndrome completely asymptomatic in the previous years, presented to our department with recent onset of dizziness and fatigue.
September 7, 2011
An 18-year-old woman with no known medical history presented to the ED complaining of fever, chills, and rigors of a week’s duration. The patient appeared very ill with hypotension, tachycardia, tachypnea, and fever.
CARDIO VASCULAR DISEASES MEDICATIONS
SearchMedica Search Result
Find peer-reviewed literature and websites for practicing medical professionals